Aeon Biopharma Inc (AEON) Stock Price, Quote & News

Company Profile

AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceu...

Industry: Biotechnology

Sector: Healthcare

Phone: 949 354 6499

Website: www.aeonbiopharma.com

Address:

5 Park Plaza, Suite 1750, Irvine, United States

BryceyBoy Dec. 24 at 12:11 PM

$AEON Been a boring week so far for this one. But, better than bad news.

1 · Reply

VXRT007 Dec. 23 at 10:47 PM

$AEON Anyone watching the $1 show.....

0 · Reply

TWITLIEDETECTOR Dec. 23 at 2:02 AM

$AEON someone is trying to keep this over a dollar

0 · Reply

BryceyBoy Dec. 22 at 1:02 PM

$AEON Curious to see what happens this week for AEON! Hoping for another week of green.

0 · Reply

StockScanners Dec. 20 at 6:37 PM

$AEON reached 1.13

0 · Reply

VinWeezel Dec. 20 at 4:09 PM

$AEON apb450 has the bio similar designation in other countries, Daewoong already makes apb450 in a facility that is fda approved, aeon has rights to apb450 in US, Canada, Europe and elsewhere. CEO Rob Bancroft has the balance sheet in order, stock price doubled since his insider buy. Current market cap around 14 million.

0 · Reply

TWITLIEDETECTOR Dec. 20 at 3:03 AM

$AEON inducement grant pr

0 · Reply

flywithfitz81 Dec. 19 at 8:56 PM

$AEON bought in too high, but wtf. This gal looks to have legs.

1 · Reply

BryceyBoy Dec. 19 at 8:16 PM

$AEON What is everyone's thoughts at the moment? Where do you think it will rise to once they have the FDA meeting and how long until it gets there? Curious how everyone feels about it.

1 · Reply

Tidianecheikh Dec. 19 at 7:42 PM

$AEON waiting for the DIAMOND, soon we will get rewarded 🎉💪🥳

0 · Reply

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

Dec 15, 2025, 4:05 PM EST - 9 days ago

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

Nov 20, 2025, 8:30 AM EST - 5 weeks ago

AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling

Nov 14, 2025, 8:30 AM EST - 5 weeks ago

AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth

Nov 13, 2025, 8:30 AM EST - 6 weeks ago

AEON Biopharma Announces Fundraise Totaling Up to ~$22 Million through Private Placement and Proposed Exchange of Daewoong Convertible Notes

Oct 1, 2025, 8:00 AM EDT - 3 months ago

AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19

Aug 12, 2025, 4:05 PM EDT - 4 months ago

AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update

May 19, 2025, 4:05 PM EDT - 7 months ago

AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025

May 14, 2025, 4:05 PM EDT - 8 months ago

AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

Apr 25, 2025, 4:05 PM EDT - 8 months ago

AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance

Apr 21, 2025, 4:05 PM EDT - 8 months ago

AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer

Mar 27, 2025, 4:05 PM EDT - 9 months ago

AEON Biopharma Announces CEO Transition

Mar 24, 2025, 4:05 PM EDT - 9 months ago

AEON Biopharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Mar 4, 2025, 8:00 AM EST - 10 months ago

AEON Biopharma, Inc. to Participate in the Leerink Global Healthcare Conference

Feb 24, 2025, 2:00 PM EST - 10 months ago

AEON Biopharma, Inc. Announces Reverse Stock Split

Feb 7, 2025, 4:05 PM EST - 11 months ago

AEON Biopharma, Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

Jan 7, 2025, 9:37 AM EST - 1 year ago

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

Jan 3, 2025, 8:02 PM EST - 1 year ago

AEON Biopharma, Inc. Announces Launch of Proposed Public Offering

Nov 13, 2024, 4:05 PM EST - 1 year ago

AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Aug 19, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024

Aug 12, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

May 29, 2024, 8:00 AM EDT - 1 year ago

AEON Biopharma Announces Strategic Resource Reprioritization and Cost Reduction Plan

May 14, 2024, 4:05 PM EDT - 1 year ago

AEON Biopharma Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 1 year ago

AEON Biopharma Provides Update on Development Pipeline

May 3, 2024, 7:00 AM EDT - 1 year ago

AEON Biopharma Announces Preliminary Top-Line Results from Phase 2 Interim Analysis of ABP-450 in the Preventive Treatment of Chronic Migraine

Mar 30, 2024, 10:53 PM EDT - 1 year ago

CORRECTION -- AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 4:15 PM EDT - 1 year ago

AEON Biopharma Announces Redemption of Public Warrants

Mar 29, 2024, 3:45 PM EDT - 1 year ago

AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results

Mar 19, 2024, 4:30 PM EDT - 1 year ago

AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine

Mar 19, 2024, 4:29 PM EDT - 1 year ago

AEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase Agreements

Jan 18, 2024, 4:05 PM EST - 2 years ago

AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference

Dec 12, 2023, 8:00 AM EST - 2 years ago

AEON Biopharma Completes Enrollment in Phase 2 Study of ABP-450 (prabotulinumtoxinA) for Preventive Treatment of Chronic Migraine

Nov 13, 2023, 8:15 AM EST - 2 years ago

AEON Biopharma Reports Third Quarter 2023 Financial Results

Oct 19, 2023, 4:05 PM EDT - 2 years ago

AEON Biopharma Announces Topline Results from Phase 2 Trial of ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Episodic Migraine

Aug 29, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Presents Positive Results from Phase 2 Clinical Trial of ABP-450 (prabotulinumtoxinA) in Cervical Dystonia at the International Parkinson and Movement Disorders Society Congress®

Aug 24, 2023, 8:00 AM EDT - 2 years ago

AEON Biopharma Receives Notice of Allowance from USPTO for a Patent Covering Use of Botulinum Toxins to Treat Migraine Headache

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Strathspey Crown Holdings Group, LLC Provides Clarifying Statement Regarding Form 4 Filing with SEC for Holdings in AEON Biopharma

Jul 24, 2023, 7:00 AM EDT - 2 years ago

AEON Biopharma Announces Closing of Business Combination with Priveterra Acquisition Corp. and Provides Pipeline Update

BryceyBoy Dec. 24 at 12:11 PM

$AEON Been a boring week so far for this one. But, better than bad news.

1 · Reply

VXRT007 Dec. 23 at 10:47 PM

$AEON Anyone watching the $1 show.....

0 · Reply

TWITLIEDETECTOR Dec. 23 at 2:02 AM

$AEON someone is trying to keep this over a dollar

0 · Reply

BryceyBoy Dec. 22 at 1:02 PM

$AEON Curious to see what happens this week for AEON! Hoping for another week of green.

0 · Reply

StockScanners Dec. 20 at 6:37 PM

$AEON reached 1.13

0 · Reply

VinWeezel Dec. 20 at 4:09 PM

0 · Reply

TWITLIEDETECTOR Dec. 20 at 3:03 AM

$AEON inducement grant pr

0 · Reply

flywithfitz81 Dec. 19 at 8:56 PM

$AEON bought in too high, but wtf. This gal looks to have legs.

1 · Reply

BryceyBoy Dec. 19 at 8:16 PM

$AEON What is everyone's thoughts at the moment? Where do you think it will rise to once they have the FDA meeting and how long until it gets there? Curious how everyone feels about it.

1 · Reply

Tidianecheikh Dec. 19 at 7:42 PM

$AEON waiting for the DIAMOND, soon we will get rewarded 🎉💪🥳

0 · Reply

TWITLIEDETECTOR Dec. 19 at 7:16 PM

$AEON

0 · Reply

BUKUDATBULL Dec. 19 at 6:27 PM

O and DO NOT FORGET BOUT THIS ONE ☝️ $AEON 🤫$$$$

0 · Reply

Mandi63 Dec. 19 at 4:51 PM

$AEON …$25.00

1 · Reply

JayM13 Dec. 19 at 8:12 AM

$AEON 👀

0 · Reply

Pidxr Dec. 18 at 3:56 AM

$AEON

0 · Reply

Moonster25 Dec. 18 at 12:38 AM

$AEON Should have sold yesterday and bought back in, this thing always tanks after a good day, smh

0 · Reply

BryceyBoy Dec. 17 at 6:40 PM

$AEON Lets get this everyone! Been holding out for a long time and hoping it pays off in the next month.

0 · Reply

Pidxr Dec. 17 at 5:54 PM

$AEON picked up a little more there under a dollar

1 · Reply

TraderManfromUK Dec. 17 at 9:23 AM

$AEON Reversal has started and in a very strong way !! From $0.63 to $1.10 Brilliant recovery .. only up from here and those mini dips are acceptable ✅

0 · Reply

StockScanners Dec. 17 at 1:08 AM

$AEON keep watch if this holds above .90

1 · Reply

HalEugene Dec. 16 at 10:15 PM

$AEON https://www.globalgrowthinsights.com/market-reports/botox-market-119837 In case you all are bored and want some light reading. Regards!!

0 · Reply

BigD_Love Dec. 16 at 5:36 PM

$AEON THIS. RIGHT. HERE. 👇🏻🚀👇🏻🚀

0 · Reply

Market Cap	12.19M
Revenue (ttm)	0.00
Net Income (ttm)	42.01M
EPS (ttm)	N/A
PE Ratio	0.39
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	133,900
Avg Vol	253,946
Day's Range	N/A - N/A
Shares Out	11.84M
Stochastic %K	80%
Beta	0.75
Analysts	Strong Sell
Price Target	$6.10